Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa

Journal of Medical Virology

Volumn 51, Issue 2, 1997, Pages 126-131

  Marais, Dianne ^a   Rose, Robert C ^b   Williamson, Anna Lise ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

CIN; ELISA; HPV 16; HPV 18; serology; virus like particles

Indexed keywords

VIRUS ANTIBODY;

ARTICLE; BLOOD DONOR; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; PAPILLOMA VIRUS; SCREENING; UTERINE CERVIX CANCER; VIRUS DETECTION;

ADULT; AGE DISTRIBUTION; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; BLOOD DONORS; CAPSID PROTEINS; CATTLE; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SOUTH AFRICA; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PARVOVIRUS; CANCER VIRUS; HUMAN PAPILLOMA VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 0031046821     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199702)51:2<126::AID-JMV7>3.0.CO;2-9     Document Type: Article

References (28)

1. Bonnez W, Da Rin C, Rose RC, Reichman RC (1991): Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies to condylomata acuminata. Journal of General Virology 72:1343-1347.
2. Cason J, Kambo PK, Best JM, McCance DJ (1992): Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type 16 (HPV 16) in sera from patients with cervical intraepithelial neoplasia and in children. International Journal of Cancer 50:349-355.
3. Cason C, Kaye JN, Jewers RJ, Kambo PK, Bible JM, Kell B, Shergill B, Parkarian K, Raju S, Best JM (1995): Perinatal infection and persistance of human papillomavirus types 16 and 18 in infants. Journal of Medical Virology 47:209-218.
4. Dillner J (1990): Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6, and E7 open reading frames. International Journal of Cancer 46:703-711.
5. Dillner J (1994): Antibody responses to defined HPV epitopes in cervical neoplasia. Papillomavirus Report 5:35-41.
6. Dillner J, Lenner P, Lehtinen M, Eklund C, Heio P, Wiklund F, Hallmans G, Stendahl U (1994): A population-based seroepidemiological study of cervical cancer. Cancer Research 54:134-141.
7. Dillner J, Dillner L, Robb J, Willems J, Jones I, Lancaster W, Smith R, Lerner R (1989): A synthetic peptide defines a serological IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proceedings of the National Academy of Sciences of the USA 86:3838-3841.
8. Dillner J, Wiklund F, Lenner P, Eklund C, Fredriksson-Shanazarian V, Schiller JT, Hibma M, Hallmans G, Stendahl U (1995): Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cancer. International Journal of Cancer 60:377-382.
9. Galloway DA (1994): Papillomavirus capsids: a new approach to identify serological markers of HPV infection. Journal of the National Cancer Institute 86:474-475.
10. Ghim S-J, Young R, Bennett Jenson A (1996): Antigenicity of bovine papillomavirus type 1 (BPV-1) L1 virus-like particles compared with that of intact BPV-1 virions. Journal of General Virology 77:183-188.
11. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT (1994): A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. Journal of the National Cancer Institute 86:494-499.
12. Melkert PWJ, Hopman E, van den Brule AJC, Risse EKJ, Walboomers JMM (1993): Prevalence of HPV in cytomorphologically normal cervical smears determined by the polymerase chain reaction is age dependent. International Journal of Cancer 53(6):919-923.
13. Muller M, Viscidi RP, Ulken V, Bavinck JNB, Hill PM, Fisher SG, Reid R, Munoz N, Schneider A, Shah KV, Gissman L (1995): Antibodies to the E4, E6 and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population. The Journal of Investigative Dermatology 104:138-141.
14. Nonnemacher B, Hubbert N, Kirnbauer R, Shah KV, Munoz N, Bosch FX, de Sanjose' S, Viscidi R, Lowy DR, Schiller J (1995): Serological response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cancer and cervical intraepithelial neoplasia grade III patients and controls from Columbia and Spain. Journal of Infectious Disease 172:19-24.
15. Pater M, Mittal R, Pater A (1994): Role of steroid hormone in potentiating transformation of cervical cells by human papillomavirus. Trends in Microbiology 2(7):229-235.
16. Pfister H, Fuchs PG (1987): Papillomaviruses: Particles, genome organisation and proteins. In Syrjänen K, Gissman L, Koss LG (eds): "Papillomaviruses and Human Disease." Berlin: Springer-Verlag, p 10.
17. Ramesar JE, Dehaek CMC, Soeters R, Williamson A-L (1996): The detection of human papillomavirus in normal scrapes from Cape Town, South Africa. South African Medical Journal (in press).
18. Rose RC, Bonnez W, Strike DG, Reichman RC (1990): Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles. Journal of General Virology 71:2725-2729.
19. Rose RC, Bonnez W, Reichman RC, Gracea RL (1993): Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of virus-like particles. Journal of Virology 67:1936-1944.
20. Rose RC, Reichman RC, Bonnez W (1994a): Human papilloma (HPV) type 11 recombinant virus-like particles induce the formation of neutralising antibodies and detect HPV-specific antibodies in human sera. Journal of General Virology 75:2075-2079.
21. Rose RC, Bonnez W, Da Rin C, McCance J, Reichman RC (1994b): Serological differentiation of human papillomavirus types 11, 16, and 18 using virus-like particles. Journal of General Virology 75:2445-2449.
22. Schiffman M (1992): Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. Journal of the National Cancer Institute 84:394-398.
23. Schiller JT, Roden RBS (1995): Papillomavirus-like particles. Papillomavirus Report 6:121-128.
24. Sitas F, Pacella R (1994): National cancer registry. Annual statistical report for 1989. Incidence of histologically diagnosed cancer in South Africa. Johannesburg: South African Institute for Medical Research 1994.
25. Wikström A, van Dornum JJ, Quint GV, Schiller JT, Dillner J (1995): Identification of human papillomavirus seroconversions. Journal of General Virology 76:529-539.
26. Williamson A-L, Deheak CMC, Soeters R (1989): Typing of human Papillomaviruses in cervical intraepithelial neoplasia grade 3 biopsies from Cape Town. Journal of Medical Virology 28:146-149.
27. Williamson A-L, Brink NS, Dehaeck CMC, Ovens S, Soeters R, Rybicki EP (1994): Typing of human Papillomaviruses in cervical carcinoma biopsies from Cape Town. Journal of Medical Virology 43:231-237.
28. zur Hausen H (1994): Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Current Topics in Microbiology and Immunology 186:131-156.